| Varghese Kodiyan Pa | |
|
602 Shellcracker Ct Tampa FL 33613 | |
| (813) 245-7326 | |
| Not Available |
| Full Name | Varghese Kodiyan Pa |
|---|---|
| Speciality | Social Worker |
| Location | 602 Shellcracker Ct, Tampa, Florida |
| Authorized Official Name and Position | Varghese Kodiyan (PRESIDENT) |
| Authorized Official Contact | 8132457326 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Varghese Kodiyan Pa 602 Shellcracker Ct Tampa FL 33613-1214 Ph: (813) 245-7326 | Varghese Kodiyan Pa 602 Shellcracker Ct Tampa FL 33613 Ph: (813) 245-7326 |
| NPI Number | 1003175753 |
|---|---|
| Provider Enumeration Date | 05/15/2012 |
| Last Update Date | 05/15/2012 |
| Medicare PECOS PAC ID | 6204090426 |
|---|---|
| Medicare Enrollment ID | O20120619000308 |
News Archive
Researchers at the University of Cincinnati College of Medicine have identified for the first time that the estrogen receptor-binding protein MED1 is a critical mediator of HER2-driven breast cancer, identifying it as a potential therapeutic target.
A small study from Massachusetts General Hospital (MGH) researchers found that online virtual communities may be an effective way to train patients in meditation and other mind/body techniques. The ability to learn and practice approaches that elicit the relaxation response - a state of deep rest that has been shown to alleviate stress-related symptoms - in a virtual environment could help surmount several barriers that can restrict participation.
Oramed Pharmaceuticals Inc., a developer of alternative drug delivery systems, reported today results for the recently completed Phase 2b non-FDA clinical trial of its flagship oral insulin capsule, ORMD-0801.
NeuroVasx, Inc., a medical device company that develops technologies for the treatment of hemorrhagic and ischemic stroke, announced today that it has received approval to market its cPAX Aneurysm Treatment System in Canada from Health Canada's Therapeutic Products Directorate. In addition to Canadian regulatory approval, the cPAX System also received CE Mark in March 2009.
"Representatives from more than 100 governments around the world, health experts, civil society organizations and other stakeholders are converging in Rio de Janeiro, Brazil for three days" at the WHO-convened World Conference on Social Determinants of Health "to discuss how social, economic and environmental conditions could be improved to reduce the health gaps within and between countries," a WHO press release states.
› Verified 9 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003175753 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | (* (Not Available)) | Primary |
| Provider Name | Varghese Kodiyan |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1326084435 PECOS PAC ID: 6709040934 Enrollment ID: I20120619000504 |
News Archive
Researchers at the University of Cincinnati College of Medicine have identified for the first time that the estrogen receptor-binding protein MED1 is a critical mediator of HER2-driven breast cancer, identifying it as a potential therapeutic target.
A small study from Massachusetts General Hospital (MGH) researchers found that online virtual communities may be an effective way to train patients in meditation and other mind/body techniques. The ability to learn and practice approaches that elicit the relaxation response - a state of deep rest that has been shown to alleviate stress-related symptoms - in a virtual environment could help surmount several barriers that can restrict participation.
Oramed Pharmaceuticals Inc., a developer of alternative drug delivery systems, reported today results for the recently completed Phase 2b non-FDA clinical trial of its flagship oral insulin capsule, ORMD-0801.
NeuroVasx, Inc., a medical device company that develops technologies for the treatment of hemorrhagic and ischemic stroke, announced today that it has received approval to market its cPAX Aneurysm Treatment System in Canada from Health Canada's Therapeutic Products Directorate. In addition to Canadian regulatory approval, the cPAX System also received CE Mark in March 2009.
"Representatives from more than 100 governments around the world, health experts, civil society organizations and other stakeholders are converging in Rio de Janeiro, Brazil for three days" at the WHO-convened World Conference on Social Determinants of Health "to discuss how social, economic and environmental conditions could be improved to reduce the health gaps within and between countries," a WHO press release states.
› Verified 9 days ago
News Archive
Researchers at the University of Cincinnati College of Medicine have identified for the first time that the estrogen receptor-binding protein MED1 is a critical mediator of HER2-driven breast cancer, identifying it as a potential therapeutic target.
A small study from Massachusetts General Hospital (MGH) researchers found that online virtual communities may be an effective way to train patients in meditation and other mind/body techniques. The ability to learn and practice approaches that elicit the relaxation response - a state of deep rest that has been shown to alleviate stress-related symptoms - in a virtual environment could help surmount several barriers that can restrict participation.
Oramed Pharmaceuticals Inc., a developer of alternative drug delivery systems, reported today results for the recently completed Phase 2b non-FDA clinical trial of its flagship oral insulin capsule, ORMD-0801.
NeuroVasx, Inc., a medical device company that develops technologies for the treatment of hemorrhagic and ischemic stroke, announced today that it has received approval to market its cPAX Aneurysm Treatment System in Canada from Health Canada's Therapeutic Products Directorate. In addition to Canadian regulatory approval, the cPAX System also received CE Mark in March 2009.
"Representatives from more than 100 governments around the world, health experts, civil society organizations and other stakeholders are converging in Rio de Janeiro, Brazil for three days" at the WHO-convened World Conference on Social Determinants of Health "to discuss how social, economic and environmental conditions could be improved to reduce the health gaps within and between countries," a WHO press release states.
› Verified 9 days ago
Avalon Behavior Services Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1190 E Washington St, Ph29, Tampa, FL 33602 Phone: 510-313-8290 | |
Tampa Life Counseling, Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 13035 W. Linebaugh Ave #101 Ste G, Tampa, FL 33626 Phone: 813-906-8852 | |
Embracing Changes Center For Wellness Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 4830 W Kennedy Blvd Ste 630, Tampa, FL 33609 Phone: 813-486-4920 Fax: 813-428-5756 | |
Vip Senior Wellness Services Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 10115 Vista Pointe Dr, Tampa, FL 33635 Phone: 718-942-6595 | |
Crudup Psychological Services Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 10001 Cross Creek Blvd, Tampa, FL 33647 Phone: 386-243-9220 | |
Grow, Empower, Transform Therapy, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 13542 N Florida Ave Ste 210, Tampa, FL 33613 Phone: 813-563-8227 |